Attached files
file | filename |
---|---|
10-K - FORM 10-K - REGENERX BIOPHARMACEUTICALS INC | c98562e10vk.htm |
EX-32.2 - EXHIBIT 32.2 - REGENERX BIOPHARMACEUTICALS INC | c98562exv32w2.htm |
EX-31.1 - EXHIBIT 31.1 - REGENERX BIOPHARMACEUTICALS INC | c98562exv31w1.htm |
EX-31.2 - EXHIBIT 31.2 - REGENERX BIOPHARMACEUTICALS INC | c98562exv31w2.htm |
EX-32.1 - EXHIBIT 32.1 - REGENERX BIOPHARMACEUTICALS INC | c98562exv32w1.htm |
EX-10.25 - EXHIBIT 10.25 - REGENERX BIOPHARMACEUTICALS INC | c98562exv10w25.htm |
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
hereby consent to the incorporation by reference in the Registration Statements on Form S-3 and
related prospectuses (Registration Nos. 333-150675, 333-140415, 333-125861 and 333-122386) and
on Form S-8 (Registration Nos. 333-152250 and 333-111386) of RegeneRx Biopharmaceuticals, Inc. of
our report dated March 31, 2010, with respect to the financial statements of RegeneRx
Biopharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December
31, 2009.
/s/ Reznick Group, P.C.
Vienna, Virginia
March 31, 2010
March 31, 2010